SOURCE: Endexx Corporation

Endexx Corporation

August 27, 2014 08:00 ET

Endexx to Present at Aegis Capital 2014 Healthcare & Technology Conference

First Organic and Eco-Farming CBD Extract Crop Confirmed

CAVE CREEK, AZ--(Marketwired - Aug 27, 2014) - Endexx Corporation (OTC Pink: EDXC) (PINKSHEETS: EDXC), a provider of innovative medical marijuana management and technology solutions(M3hub), today announced that it will present at the Aegis Capital 2014 Healthcare & Technology Conference in Las Vegas.

Event: Aegis 2014 Healthcare & Technology Conference
Location: The Encore at Wynn Las Vegas
Date: Thursday, September 11, 2014
Time: 9:00 AM (PT)
Room: 1

Todd Davis, Founder and CEO of Endexx, will present a corporate overview and update investors on the deployment and expansion of the M3Hub technology and services platform into new markets, present near term revenue guidance and a take a fresh look at the underlying value of its offering based on the projected exponential growth of the industry.

Todd Davis will be available during the conference for one-on-one meetings with investors. 

To arrange a one-on-one meeting with management, please contact Robert Haag at or 1-866-976-4784.

In further news, Endexx today announced it will be receiving next week its first order of organic high-grade Cannabidiol (CBD) extract from an industrial hemp cultivation and processing facility using eco-farming standards that promote biodiversity and do not contaminate the environment with chemical inputs and genetic engineering. The pharmacy grade extract is free of contaminants and will be used to conduct formulation testing, clinical trials and for the initial launch of our Cannsumable-CBD infused and vaporizer products scheduled for early October.

About Endexx
Endexx provides innovative medical marijuana management and technology solutions. The Company has two products that launched beta in the first half of 2014 -- the m3hub and the Autospense™. Both products provide essential solutions to promote regulatory compliance and full accountability through "seed to sale", plant lifecycle, inventory management and tracking. Based on principles developed by the pharmacological industry, the m3hub database is the first standardized software platform for tracking pharmaceutical grade marijuana to support a Centralized Medical Marijuana Industry Repository and maintain compliance with the laws of the federal government and state and local regulatory bodies. The Autospense™ is a high-tech marijuana inventory control and dispensing machine, which provides up to the minute accounting details and protects the security of the product as well as the patient. By automating the dispensing process, Autospense™ increases productivity and reduces costs for marijuana retailers, while enhancing their service quality by reducing transaction time for customers.,,

Safe Harbor Notice
This press release may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future development activities, and are thus prospective. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the Company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company's ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with the Company's business and finances in general, including the ability to continue and manage its growth, competition, global economic conditions and other factors discussed in detail in the Company's periodic filings with the Security and Exchange Commission. The Company undertakes no obligation to update any forward-looking statements.

Contact Information